Saxenda (Liraglutide)
$50.00
Saxenda (Liraglutide) is an injectable prescription medicine that contains Liraglutide and is used for chronic weight management in adults.
Available: 3mg, 6mg
In Stock (75 available)
Why Choose Saxenda?
FDA-approved specifically for weight management. Daily dosing allows for flexible timing and gradual dose escalation.
How to Use
Inject subcutaneously once daily at any time of day, with or without meals. Start with 0.6mg daily and increase dose gradually as tolerated.
Safety Information
Contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Risk of pancreatitis.
Potential Side Effects
Nausea, hypoglycemia, diarrhea, constipation, vomiting, headache, and decreased appetite. Side effects are often dose-dependent.
Product Facts
| Generic Name | Liraglutide |
| Brand Name | Saxenda |
| Type of Medication | Glucagon-like peptide-1 (GLP-1) receptor agonist |
| FDA Approval Date | December 23, 2014 |
| Indications | Chronic weight management in adults with obesity or overweight with at least one weight-related condition. |
| Dosage Forms | Subcutaneous injection (pre-filled pen) |
| Administration | Once daily |
| Special Precautions | Boxed warning for thyroid C-cell tumors. Monitor for pancreatitis, gallbladder disease, and renal impairment. |
| Drug Interactions | May enhance the hypoglycemic effect of insulin and sulfonylureas. Slows gastric emptying affecting oral drug absorption. |
| Use in Specific Populations | Not recommended during pregnancy. Safety and effectiveness in pediatric patients have not been established. |
| Prescription | Prescription required |
| Manufacturer | Novo Nordisk |
How to Buy
Available by prescription only. Requires healthcare provider consultation and proper training on injection technique.